Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Letter

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Jan 04, 2023 12:05pm

137 Views

Post# 35202877

RE:RE:Letter

There were those holding the stock in expectations that Th 1902 woukd be an instant success ....When the pause was announced they ran for the exit .....I dont think the letter woud have changed much then......I agree that comunication can be improved ...if there are FACTS

qwerty22 wrote:
Paul the SP is up because you talked. Learn.

Scioto wrote: Small step. But important. Need to build-up relationship brick by brick. Communication is critical.